Fundraising Fox

Enable Injections

Cincinnati, US · Founded 2010 · Delaware corporation · 225 employees on LinkedIn · 6 known investors

Enable Injections develops and manufactures enFuse, a wearable drug delivery device that delivers large volumes of pharmaceutical and biologic therapeutics subcutaneously for patients with chronic diseases. The company serves healthcare providers, payers, and patients by offering a mechanical hands-free alternative to intravenous treatment.

BiotechHealthtechMedical Devices

Founders & leadership

Enable Injections was founded in 2010 by Mike Hooven.

MHMike Hooven
Mike HoovenChairman, President and CEO
TF
Timothy FlahertyExecutive
SS
Simone SongNamed on SEC filing
KR
Karen RobardsNamed on SEC filing
RJ
Richard J D'AugustineNamed on SEC filing
NR
Norman R. WeldonNamed on SEC filing

Board

JR
John RiceBoard director

Investors · 6

Angel Physicians Fund
CincyTechCincinnati · $500K – $750K
Lightship CapitalCincinnati · $100K – $10M
Ohio Innovation FundDublin · $500K – $4M
Magnetar AI VenturesreportedEvanstonvia Erik Falk · board
Versant VenturesreportedSan Francisco · $250K – $5Mvia Beckie Robertson · board

Reported raises · per SEC filings

Form D private placements

$245M disclosed across 9 of 11 rounds · 2012–2025

▶$30MraisedJan 2026 · 1 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Jim CollinsDirector
  • Simone SongDirector
  • Richard J. D'AugustineDirector
  • John RiceDirector
  • David KroekelExecutive Officer
  • John DeFordDirector
  • Matt HuddlestonExecutive Officer
  • Timothy FlahertyExecutive Officer
  • Beckie RobertsonDirector
  • Michael D. HoovenExecutive Officer, Director
  • Erik FalkDirector
  • Nigel SheailDirector
  • Vickie CappsDirector
Offering amount
$30M
Amount sold
$30M
Minimum investment
$1
First sale
Dec 2025
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$150MraisedFeb 2022 · 22 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • John RiceDirector
  • Timothy FlahertyExecutive Officer
  • Michael D. HoovenExecutive Officer, Director
  • Simone SongDirector
  • Karen RobardsDirector
  • Richard J D'AugustineDirector
  • Norman R. WeldonDirector
Offering amount
$215M
Amount sold
$150M
Minimum investment
$1
Sales commissions
$8.3M
First sale
Jan 2022
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$30.7MraisedOct 2018 · 15 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Richard D'AugustineDirector
  • Timothy FlahertyExecutive Officer
  • Mark A. CollarDirector
  • Michael D. HoovenExecutive Officer, Director
  • Norman WeldonDirector
  • John RiceDirector
  • Daniel von AllmenDirector
  • Simone SongDirector
  • Susan SpiesExecutive Officer
Offering amount
$50M
Amount sold
$30.7M
Minimum investment
$1
First sale
Oct 2018
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$25MraisedNov 2016 · 1 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Susan SpiesExecutive Officer
  • Michael HoovenExecutive Officer
  • Timothy FlahertyExecutive Officer
Offering amount
$25M
Amount sold
$25M
First sale
Aug 2016
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$22.9KraisedAug 2016 · 1 investors · Other Health Care
Officers, directors & promoters on the filing
  • Susan SpiesExecutive Officer
  • Michael HoovenExecutive Officer
  • Timothy FlahertyExecutive Officer
Offering amount
$22.9K
Amount sold
$22.9K
First sale
Jun 2014
Incorporated
Limited Liability Company, Delaware
Federal exemptions
04
Full filing on SEC EDGAR ↗
▶$2MraisedAug 2016 · 13 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Michael HoovenExecutive Officer
  • Timothy FlahertyExecutive Officer
  • Susan SpiesExecutive Officer
Offering amount
$2M
Amount sold
$2M
Minimum investment
$25K
First sale
May 2012
Incorporated
Limited Liability Company, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$5MraisedAug 2016 · 19 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Michael HoovenExecutive Officer
  • Timothy FlahertyExecutive Officer
  • Susan SpiesExecutive Officer
Offering amount
$5M
Amount sold
$5M
First sale
Jun 2016
Incorporated
Limited Liability Company, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$100KofferedAug 2016 · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Susan SpiesExecutive Officer
  • Michael HoovenExecutive Officer
  • Timothy FlahertyExecutive Officer
Offering amount
$100K
Incorporated
Limited Liability Company, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

What does Enable Injections do?
Enable Injections develops and manufactures enFuse, a wearable drug delivery device that delivers large volumes of pharmaceutical and biologic therapeutics subcutaneously for patients with chronic diseases. The company serves healthcare providers, payers, and patients by offering a mechanical hands-free alternative to intravenous treatment.
Who founded Enable Injections?
Enable Injections was founded by Mike Hooven in 2010.
Who are Enable Injections's investors?
Enable Injections's investors include Angel Physicians Fund, CincyTech, Lightship Capital, Ohio Innovation Fund, Magnetar AI Ventures, Versant Ventures.
How much funding has Enable Injections raised?
Enable Injections has disclosed $245M raised across 9 of its 11 known rounds.
Where is Enable Injections headquartered?
Enable Injections is headquartered in Cincinnati, US.